652 related articles for article (PubMed ID: 12929292)
21. [lymphatic Mapping and Sentinel Lymph Node Biopsy in patients with Breast Cancer ].
Gallegos-Hernández JF; Chávez-García MA; Nájera I; Ramírez-Ramírez L; Durán-Martínez M
Gac Med Mex; 2003; 139(3):205-8. PubMed ID: 12872412
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of sentinel node biopsy in breast cancer patients with a high prevalence of axillary metastases.
Moghimi M; Ghoddosi I; Rahimabadi AE; Sheikhvatan M
Scand J Surg; 2009; 98(1):30-3. PubMed ID: 19447739
[TBL] [Abstract][Full Text] [Related]
23. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
24. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
25. [Exclusive use of blue dye to detect sentinel lymph nodes in breast cancer].
Bühler H S; Rojas P H; Cayazzo M D; Cunill C E; Vesperinas A G; Hamilton S J
Rev Med Chil; 2008 Aug; 136(8):1015-20. PubMed ID: 18949185
[TBL] [Abstract][Full Text] [Related]
26. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Allen B; Campbell I; Desai S; Dray M; Scarlet J
N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
[TBL] [Abstract][Full Text] [Related]
27. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
28. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
29. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
30. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in breast cancer.
Sakorafas GH; Tsiotou AG
Am Surg; 2000 Jul; 66(7):667-74. PubMed ID: 10917479
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients.
Gimbergues P; Dauplat MM; Durando X; Abrial C; Le Bouedec G; Mouret-Reynier MA; Cachin F; Kwiatkowski F; Tchirkov A; Dauplat J; Penault-Llorca F
Ann Surg Oncol; 2010 Aug; 17(8):2132-7. PubMed ID: 20155400
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
36. [Sentinel lymph node biopsy and low axillary node sampling for breast cancer].
Sawai K; Nakajima H; Ohe S; Mizuta N; Sakaguchi K; Hachimine Y
Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):825-30. PubMed ID: 12478860
[TBL] [Abstract][Full Text] [Related]
37. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
39. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]